コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 d wing length as measures of an individual's frailty.
2 ive symptoms, were significant correlates of frailty.
3 n in older adults, focusing on the impact of frailty.
4 of 79.3% for high frailty and 82.3% for low frailty.
5 sociated each physical performance test with frailty.
6 telomere length, chronic disease status, and frailty.
7 physical performance test to a single factor-frailty.
8 deficits to minimize the risk of low BMD and frailty.
9 e heterogeneous than males in their level of frailty.
10 patients without significant comorbidity or frailty.
11 health is associated with a reduced risk of frailty.
12 l activity is limited by illness, ageing, or frailty.
13 alence of most comorbidities and measures of frailty.
14 e (GHD) and/or sex steroids with low BMD and frailty.
15 14-item instrument used to measure surgical frailty.
16 ns of triglyceride levels with longevity and frailty.
17 signatures discriminate HIV pathophysiologic frailty.
18 dated frailty index (FI) was used to measure frailty.
19 hould be considered in managing persons with frailty.
20 ifespan often reduce healthspan and increase frailty.
22 One-year mortality was 22% for patients with frailty, 27% for patients with dementia, and 12% in the
23 h high 1-year mortality rates: dementia with frailty (29%), frailty with chronic obstructive pulmonar
26 tion of frailty was important; adjusting for frailty alone yielded a VE estimate of 58.7% (95% CI, 36
31 the only conventional factor associated with frailty among KT recipients; however, factors rarely mea
35 Conclusions and Relevance: The prevalence of frailty among young-adult HCT survivors approaches that
36 for center-specific effects, we performed a frailty analysis, in which each center was assumed to ha
39 lliative care were notified of the patient's frailty and associated surgical risks; if indicated, per
40 Growing numbers of older people living with frailty and chronic health conditions are being referred
41 is study was the use of surrogate markers of frailty and comorbid conditions to identify patients at
43 mple included 10,034 women aged 65-84 y with frailty and complete dietary data from the Women's Healt
44 We sought to determine the prevalence of frailty and dementia among older adults receiving primar
46 association of mortality in older women with frailty and dietary intake and healthy diet indexes, suc
47 then tested the incremental contribution of frailty and disability markers to the model's discrimina
50 s, has construct validity for the concept of frailty and improves risk prediction of waitlist mortali
51 monstrated to extending healthspan, reducing frailty and improving stem cell function in multiple mur
52 y in the degree to which various FS estimate frailty and in the identification of particular individu
54 function influences the relationship between frailty and incident dementia, the analyses were repeate
57 t studies evaluating the association between frailty and mortality or functional status at 6 months o
59 eness of several exercise modes in reversing frailty and preventing reduction in muscle and bone mass
61 ening of patients preoperatively to identify frailty and the efficacy of system-level initiatives aim
62 the impact of novel indices of comorbidity, frailty, and disability on outcomes after transcatheter
63 ferent FS are based on different concepts of frailty, and most pairs cannot be assumed to be intercha
64 ter FSI implementation, controlling for age, frailty, and predicted mortality (adjusted odds ratio fo
65 used proxy of muscular fitness, a marker of frailty, and predictor of a range of morbidities and all
67 Thus, a larger number of females with low frailty are able to survive to older ages than males, wi
85 IDU+/HCV+-associated CpGs discriminated HIV frailty based upon a validated index with an area under
86 uit and vegetables (FVs) may protect against frailty, but to our knowledge no study has yet assessed
92 ost disease (GvHD) were at increased risk of frailty compared with autologous HCT (OR,15.02; 95% CI,
93 ed that the pooled ORs (95% CIs) of incident frailty comparing participants who consumed 1, 2, or >/=
94 correlates of frailty, the patterns of the 5 frailty components, and the risk associated with these p
103 nalytic files to determine the prevalence of frailty, dementia, and other conditions before ICD impla
104 rometry, health-related quality of life, and frailty) demonstrated good construct validity across all
106 ex-specific inferences on physical function, frailty, disability, and pharmacodynamics that all merit
107 component instruments that measure different frailty domains seemed to outperform single-component on
109 With coronary artery disease treatment, frailty generally follows a U-shaped trajectory, but the
112 s and Measures: Prevalence and predictors of frailty; impact of frailty on subsequent mortality in HC
114 s associated with a lower short-term risk of frailty in a dose-response manner, and the strongest ass
124 e aim of this study was to determine whether frailty in older adults is associated with the risk of s
127 nd function is a key contributor to physical frailty in older individuals and our current understandi
129 habilitation interventions aimed at reducing frailty in patients with cirrhosis in preparation for li
132 AI-A represent effective tools for measuring frailty in surgical populations with predictive ability
134 Objective: To determine the prevalence of frailty in young adult HCT patients (18- to 64-year-olds
135 nician reported global functioning capacity (frailty) in such patients, as well as the impact of prio
139 ny countries to make rigorous assessment for frailty increasingly important for hematologic oncologis
142 lyceride levels were not associated with the frailty index (beta = 0.008; 95% CI: -0.013, 0.029) or t
145 of literature investigating how the Modified Frailty Index (mFI), a validated measure of frailty, is
150 re sufficient data to calculate the modified Frailty Index for 1021, in which the C statistics were 0
153 res (<20th percentile), cirrhotics with poor frailty index scores (>80th percentile) were more impair
158 0.547, and the correlations of the modified Frailty Index to the RAI-A and RAI-C were 0.301 and 0.26
162 Physical frailty, as measured by the Fried Frailty Index, is increasingly recognized as a critical
164 urpose: To evaluate the evidence for various frailty instruments used to predict mortality, functiona
167 component frailty instruments, few validated frailty instruments, and potential publication bias.
168 , limited generalizability of multicomponent frailty instruments, few validated frailty instruments,
179 etary patterns on survivorship in those with frailty is yet to be examined in a well-powered cohort w
180 Frailty Index (mFI), a validated measure of frailty, is associated with unplanned readmission among
181 a and osteopenia as indicators of underlying frailty may provide complementary prognostic information
182 cipients (n = 74,859) and tested whether (1) frailty, measured immediately before KT in a novel cohor
183 ive risk adjustment for comorbid illness and frailty measures explain the higher mortality after AMI
184 es with Cox regression identified subsets of frailty measures that predicted waitlist mortality (=dea
185 independent of confounding by comorbidities, frailty measures, and laboratory markers of nutritional
186 I while adjusting for patient comorbidities, frailty measures, and laboratory markers of nutritional
187 Secondary outcomes included changes in other frailty measures, body composition, bone mineral density
189 ty predicted hospital length of stay and the frailty model had a moderately better predictive accurac
197 weeks: logistic regression) and (2) whether frailty modified the association between LOS and mortali
198 ng phenotypes - longevity ( >/=95 years) and frailty (modified Fried frailty phenotype and Rockwood f
199 ent of important clinical covariates, as did frailty (odds ratio 8.01; 95% confidence interval 1.82-3
200 rent data regarding the effect of domains of frailty on outcomes for blood cancers including myelodys
201 The long-term and population-level effect of frailty on postoperative mortality is, to our knowledge,
204 r than for younger adults, and the impact of frailty on vaccine effectiveness (VE) and outcomes is un
206 iduals aged 50 years or older indicated that frailty (OR=1.43, 95%CI 1.08-1.89, p=0.012), being a mal
207 nificant physical or cognitive disabilities, frailty, or residence in a nursing home or assisted livi
208 signed to medical therapy only showed stable frailty over the 30-month follow-up period (P value for
209 mance test was significantly associated with frailty (P < 0.01), even after adjustment for MELD or he
210 though limited by an absence of a measure of frailty, patient characteristics and treatment intensity
213 revalence and prognostic significance of the frailty phenotype in patients referred for heart transpl
216 mplifications and approximations of existing frailty phenotypes for risk prediction, there have been
218 bility did not differ between sarcopenia and frailty prediction model, reflected by chi values of 21.
220 After adjusting for current age, the odds of frailty/prefrailty were increased among men with GHD (OR
222 Targeting potentially modifiable aspects of frailty preoperatively, such as improving functional sta
225 istic screening for radiologic indicators of frailty provides an additional tool for early identifica
227 gned to PCI and CABG experienced a sustained frailty reduction, whereas those assigned to medical the
232 cs associated with the greatest reduction of frailty risk were being physically active and ideal body
233 ment, we measured frailty using the Clinical Frailty Scale (range, 1 [very fit] to 7 [severely frail]
234 those with clinical frailty (i.e., Clinical Frailty Scale score >/=5) were younger than 65 years old
236 ion to analyze associations between Clinical Frailty Scale scores and outcomes, adjusting for age, se
239 ore, Charlson comorbidity index, or clinical frailty scale were independently predictive of Palliativ
240 emia, and hypoalbuminemia outperformed other frailty scales and is recommended for use in this settin
241 incremental predictive value of 7 different frailty scales to predict poor outcomes following TAVR o
245 e from illness onset to specimen collection, frailty score, and Charlson comorbidity index (CCI).
248 ogy: the exchange of age limits for rigorous frailty screening, development of disease-specific measu
255 may be improved by integrating a measure of frailty, such as 5-m gait speed, to better capture the h
256 American Society of Anesthesiologists score, frailty, surgery for malignancy, and postoperative compl
257 to assess construct validity with regard to frailty syndrome characterization and predictive validit
260 n, enhances insulin sensitivity, and reduces frailty, targeting this fundamental mechanism to prevent
263 , it is through their effect on the level of frailty that they affect age patterns of mortality.
264 firmed the association between nutrition and frailty, the impact of dietary intake and dietary patter
265 state for this population, the correlates of frailty, the patterns of the 5 frailty components, and t
266 and used Cox proportional hazard models with frailties to examine associations with hospital mortalit
267 on to the hospital care of older people with frailty, to inform future interventions and their evalua
268 on to the hospital care of older people with frailty, to inform future interventions and their evalua
269 is modest when used as a sole criterion for frailty, to screen older adults who could benefit from f
278 ltivariate analyses adjusted for covariates, frailty was associated among HIV-infected men with highe
291 ew and safer treatments for osteoporosis and frailty, we describe a novel series of selective androge
292 current event analysis incorporating patient frailty, we found no association between readmissions an
293 gether, the pooled ORs (95% CIs) of incident frailty were 0.41 (0.21, 0.60), 0.47 (0.25, 0.68), 0.36
294 tors that were independently associated with frailty were IADL disability (PR, 3.22; 95% CI, 1.72-6.0
297 ortality rates: dementia with frailty (29%), frailty with chronic obstructive pulmonary disease (25%)
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。